Differentiating intraductal papillary mucinous neoplasms from other pancreatic cystic lesions
- PMID: 21160839
- PMCID: PMC2999201
- DOI: 10.4240/wjgs.v2.i10.331
Differentiating intraductal papillary mucinous neoplasms from other pancreatic cystic lesions
Abstract
Intraductal papillary mucinous neoplasms (IPMN) can be difficult to distinguish from other cystic lesions of the pancreas. To understand better and discuss the current knowledge on this topic, the literature and the institutional experience at a large pancreatic disease center have been reviewed. A combination of preoperative demographic, historical, radiographic, laboratory data, as well as postoperative pathologic analyses can often distinguish IPMN from other lesions in the differential diagnosis.
Keywords: Differential diagnosis; Intraductal papillary mucinous neoplasms; Pancreas cancer; Pancreatic cyst.
Figures
References
-
- Klöppel G, Heitz PU, Capella C, Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg. 1996;20:132–141. - PubMed
-
- Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Washington, DC: American Registry of Pathology; 2007.
-
- Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010;8:213–219. - PMC - PubMed
LinkOut - more resources
Full Text Sources
